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418 The Journal of Thoracic and CardioObjective: The study objective was to identify how the evolution of surgical
strategies influenced the outcome after the Norwood procedure.
Methods: From 1992 to 2004, 367 patients underwent the Norwood procedure
(median age, 4 days). Three surgical strategies were identified on the basis of arch
reconstruction and source of pulmonary blood flow. The arch was refashioned
without extra material in group A (n  148). The arch was reconstructed with a
pulmonary artery homograft patch in groups B (n  145) and C (n  74).
Pulmonary blood flow was supplied by a modified Blalock-Taussig shunt in groups
A and B. Pulmonary blood flow was supplied by a right ventricle to pulmonary
artery conduit in group C. Early mortality, actuarial survival, and freedom from arch
reintervention or pulmonary artery patch augmentation were analyzed.
Results: Early mortality was 28% (n  102). Actuarial survival was 62%  3% at
6 months. Early mortality was lower in group C (15%) than group A (31%) or group
B (31%; P.05). Actuarial survival at 6 months was better in group C (78% 5%)
than group A (59%  5%) or group B (58%  4%; P .05). Fifty-three patients
(14%) had arch reintervention. Freedom from arch reintervention was 76% 3% at
1 year, with univariable analysis showing no difference among groups A, B, and C
(P .71). One hundred patients (27%) required subsequent pulmonary artery patch
augmentation. Freedom from patch augmentation was 61% 3% at 1 year, and was
lower in group C (3%  3%) than group A (80%  4%) or group B (72%  5%;
P .05).
Conclusions: Survival after the Norwood procedure improved after the introduction
of a right ventricle to pulmonary artery conduit, but a greater proportion of patients
required subsequent pulmonary artery patch augmentation. The type of arch recon-
struction did not affect the incidence of arch reintervention.
Hypoplastic left heart syndrome (HLHS) refers to a spectrum of congenitalcardiac abnormalities that are characterized by severe stenosis or atresia ofthe mitral and aortic valves, a diminutive ascending aorta, and left ventric-
ular hypoplasia.1 Coarctation is usually associated with this lesion and contributes
to reduce retrograde blood flow into the ascending aorta.2 The left ventricle is unable
to support the systemic circulation, which must be maintained by the right ventricle
through a patent ductus arteriosus. HLHS accounts for 2.5% of congenital heart
defects but is responsible for up to 25% of all deaths from congenital heart defects
within the first week of life.3 Without surgical palliation, 95% of children with
HLHS die within the first month of life.4
More than 20 years ago Dr Norwood reported the first successful surgical
palliation of HLHS.5,6 The first stage of this surgical palliation is now commonly
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Dcalled the Norwood procedure (NP). The aim of the NP is to
establish unobstructed systemic and coronary blood flow
from the right ventricle, and unobstructed pulmonary ve-
nous return across the atrial septum, and ensure adequate
pulmonary blood flow without causing volume overload.
Over the years, there has been a substantial improvement in
the outcome after surgical palliation for HLHS. This has
been attributed to refinements in the surgical technique and
perioperative medical management care, together with a
better understanding of the postoperative physiology.7
The success of the NP in HLHS has allowed the appli-
cation of this procedure to other different pathologies, char-
acterized by systemic outflow tract obstruction and func-
tionally single ventricle anatomy. The early survival after
the NP in contemporary series varies between 70% and
80%,8-12 although an increasing number of centers have
reported survivals of greater than 90% in the hospital.13-16
The aim of this study was to determine the influence of
different surgical strategies and techniques used at our institu-
tion on outcome after the NP for all patients with classic HLHS
or systemic outflow tract obstruction associated with either
right or left ventricular hypoplasia, focusing particularly on
aortic arch reconstruction and pulmonary blood flow supply.
Patients and Methods
Between November 1992 and August 2004, 367 patients with
functionally single ventricle anatomy and systemic outflow tract
obstruction underwent the NP at the Diana Princess of Wales
Children’s Hospital, Birmingham, United Kingdom. Most of the
patients had a right ventricle-dependent systemic circulation (n 
333, 91%; Table 1). The median age at operation was 4 days
(range, 0-217 days). The majority (n  283, 77%) underwent
operation within the first 7 days, and only 19 (5.2%) underwent
operation at more than 30 days of age.
All operations were performed using deep hypothermic cardio-
pulmonary bypass with periods of circulatory arrest for arch re-
construction. Myocardial protection was provided using a single
dose of cold crystalloid cardioplegia (St Thomas Hospital solution
type 1, 30 mL/kg1) administered through the side arm of the
arterial cannula before circulatory arrest. Antegrade cerebral per-
fusion, introduced in September 2002, was used during arch re-
construction in all patients with head and neck vessels of adequate
size to accommodate the arterial cannula. The remainder of the
Abbreviations and Acronyms
CI  confidence interval
CPA  central pulmonary artery
HLHS  hypoplastic left heart syndrome
LR  likelihood ratio
MBTS modified Blalock-Taussig shunt
NP  Norwood procedure
RV-PA right ventricle to pulmonary arteryoperative strategy remained unchanged throughout the study pe-
The Journal of Thoraciriod, as previously described.17 In particular, neither modified
ultrafiltration nor aprotinin was used during surgery. The median
duration of cardiopulmonary bypass, aortic crossclamp, and deep
hypothermic circulatory arrest times were 71 minutes (range, 17-
323 minutes), 51 minutes (range, 0-109 minutes), and 55 minutes
(range, 0-121 minutes), respectively. The median period of car-
diopulmonary support (ie, cumulative duration of cardiopulmo-
nary bypass and deep hypothermic circulatory arrest) was 121
minutes (range, 20-414 minutes). The atrial septum was excised
through the atrial cannulation site. Arch reconstruction was per-
formed using 1 of 2 established techniques. The original technique
involved arch reconstruction without the use of additional patch
material, as previously reported by this institution18,19 and de-
scribed by Fraser and Mee.20
All the duct tissue was excised from the aorta, disconnecting
the descending aorta from the arch. The aortic arch was opened
along the inner aspect of the ascending aorta, down to the level of
the transected proximal pulmonary artery. A complex Damus-
Kaye-Stansel anastomosis was then constructed between the aortic
arch, proximal pulmonary artery, and descending aorta (Figure 1, A).
The second technique, which has been used exclusively since
April 1999, involved arch reconstruction with a pulmonary ho-
mograft patch, as originally described by Jonas and colleagues21
with some variations. The duct tissue was completely excised only
in the presence of severe coarctation, leaving the aortic back wall
in continuity in all the other cases.
The arch was open in the inner aspect of the ascending aorta.
The incision extended as proximally as possible to allow optimal
coronary perfusion, and distally well beyond the coarctation area.
The arch was then reconstructed with pulmonary homograft ma-
terial cut to a teardrop shape. The proximal pulmonary artery was
then anastomosed to a longitudinal incision in the allograft patch
on the underside of the reconstructed neoaorta (Figure 1, B). In
those patients in whom the coarctation tissue was excised, the back
wall of the distal aortic arch and proximal descending aorta are
joined directly, and then the underside of the neoaortic arch is
augmented with allograft material.
Pulmonary blood flow was established using a modified
Blalock-Taussig shunt (MBTS) (n  293, 80%) or a right
ventricle–pulmonary artery (RV-PA) conduit (n  74, 20%). The
TABLE 1. Primary cardiac anatomy
RV-dependent circulation 333 90.7%
Classic hypoplastic left heart syndrome 290
Unbalanced atrioventricular septal defect 16
Double-outlet RV with mitral atresia 15
Critical aortic stenosis with hypoplastic LV 6
Double-inlet, double-outlet RV 3
Mitral atresia with aortic arch hypoplasia 3
LV-dependent circulation 34 9.3%
Double-inlet LV with D-TGA 20
Tricuspid atresia with D-TGA 8
D-TGA, VSD with hypoplastic RV 4
Other 2
RV, Right ventricle; LV, left ventricle; D-TGA, dextro-transposition of great
arteries; VSD, ventriculoseptal defect.MBTS consisted of a polytetrafluoroethylene tube conduit (Gore-
c and Cardiovascular Surgery ● Volume 131, Number 2 419
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DTex, WL Gore & Associates UK Ltd, Livingston, Scotland) run-
ning from the innominate artery to the upper border of the right
pulmonary artery in almost all cases (98%, n  287) (Figure 1).
The majority of patients had a 3.5-mm (59%, n  173) or
3-mm MBTS (37.2%, n  109), depending on whether the pre-
operative body weight was more or less than 2.5 kg, respectively.
A 4- or 5-mm shunt was used in a few patients (n 11). In patients
in whom an MBTS was used, the central distal pulmonary artery
defect was closed directly (29%, n  85) or by a patch (71%, n 
208) of different material (autologous pericardium, bovine peri-
cardium, or pulmonary homograft).
The RV-PA conduit was introduced in March 2002. At first, the
RV-PA conduit was taken to the left side of the ascending aorta, as
Figure 1. Norwood procedure with modified Blalock-T
additional material. B, Aortic arch reconstructed with
cava; IVC, inferior vena cava; Ao, aorta; LPA, left pul
pulmonary valve.
Figure 2. Norwood procedure with right ventricle–pu
with additional pulmonary homograft patch. A, RV-P
reconstruction. B, RV-PA conduit passes to the right sid
cava; IVC, inferior vena cava; Ao, aorta; LPA, left pul
pulmonary valve.
420 The Journal of Thoracic and Cardiovascular Surgery ● Febrdescribed by Sano and colleagues22 and other series (Figure 2,
A).23-25 In the last 51 cases performed at Birmingham Children’s
Hospital, the RV-PA conduit was passed on the right side of the
ascending aorta (Figure 2, B). In this group of patients, the defect
in the central distal pulmonary artery was closed by tailoring the
distal end of the RV-PA conduit or by a separated patch. This
technique has been used almost exclusively since February 2003.
Sixty-eight patients (92%) had a 5-mm RV-PA conduit, and 6
patients had a 4-mm RV-PA conduit, depending again on whether
the preoperative body weight was more or less than 2.5 kg,
respectively.
On the basis of the type of arch reconstruction and source of
pulmonary blood flow, 3 distinct surgical strategies were identi-
ig shunt (MBTS). A, Aortic arch reconstructed without
ional pulmonary homograft patch. SVC, Superior vena
ry artery; RV, right ventricle; TV, tricuspid valve; PV,
ary artery (RV-PA) conduit. Aortic arch reconstructed
nduit passes to the left side of the neoaortic arch
the neoaortic arch reconstruction. SVC, Superior vena
ry artery; RV, right ventricle; TV, tricuspid valve; PV,auss
addit
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Dfied. Between December 1992 and March 1999, the aortic arch was
reconstructed without additional material and pulmonary blood
flow was provided through an MBTS (group A, n 148). Between
April 1999 and March 2002 (group B, n  145), the aortic arch
was reconstructed with a pulmonary homograft patch and pulmo-
nary blood flow was supplied through an MBTS. Finally, between
March 2002 and June 2004 (group C, n  74), the aortic arch was
reconstructed with a patch of pulmonary homograft and pulmonary
blood flow was established using an RV-PA conduit.
For the purposes of this study, early mortality, actuarial sur-
vival, and actuarial freedom from arch reintervention and actuarial
freedom from subsequent patch augmentation or catheter-based
intervention of the central pulmonary arteries (CPAs) were used as
outcome measures. These were analyzed using univariable and
multivariable analyses.
This study involved the retrospective review of hospital records
and echocardiographic and cardiac catheterization data, as well as
assessment of the current clinical state. All patients have been
followed up since discharge from the hospital by a pediatric
cardiologist either in our own unit or in the patients’ referring
hospital. Follow-up was complete with a median interval of 22
months (range, 32 days-11.6 years).
Statistical Analysis
Data were examined by means of analysis of variance with a
commercial statistical software package (SPSS for Windows, ver-
sion 12; SPSS Inc, Chicago, Ill). Continuous variables are ex-
pressed as medians and ranges, and comparative univariable anal-
yses were made with the Mann-Whitney U test or Wilcoxon
signed-rank test. Binomial or ordinal data are expressed as per-
centages, and comparative univariable analyses were made with
the chi-square test, the 2-sided Fisher exact test, or binomial
logistic regression, as appropriate.
The effect of the surgical strategy on early mortality was tested
by using binomial logistic regression. The results of these multi-
variate analyses are expressed as odds ratios with 95% confidence
intervals (CIs) for variables with a P value less than.05.
Actuarial survival, freedom from reoperation, and freedom
from reintervention were estimated by using the Kaplan-Meier
product limit method. These results are expressed as a probability
estimate  1 standard error of the mean. The influence of surgical
strategies on these actuarial outcome measures have been made
with the log-rank test and a stepwise Cox regression analysis. The
results of these multivariate analyses are expressed as likelihood
ratios (LRs) with 95% CI for variables with a P value less than .05.
Results
Early mortality for the entire series was 28% (n 102), and
there were 31 late deaths. Actuarial survival was 62% 3%
at 6 months after the NP. Early mortality was lower in group
C (15%) than group A (31%) or B (31%, P .05). Early
mortality was 2.6 times lower in group C than group A or B
on multivariable analysis (odds ratio 0.38; 95% CI,
0.18-0.78). Actuarial survival at 6 months after the NP
(Figure 3, A) was better in group C (78%  5%) than group
A (59%  5%) or B (58%  4%, P .05). Actuarial
The Journal of ThoraciFigure 3. Kaplan-Meier estimated freedom from event after the
Norwood procedure. A, Actuarial survival. B, Actuarial freedom
from neoaortic arch intervention or reoperation. C, Actuarial
freedom from pulmonary artery intervention or reoperation.c and Cardiovascular Surgery ● Volume 131, Number 2 421
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multivariable analysis (LR 0.51; 95% CI, 0.30-0.86).
Fifty-three patients (14%) had neoaortic arch reinterven-
tion. In the majority of cases this was performed by balloon
angioplasty. At our institution, reintervention on the neo-
aortic arch is indicated when the gradient across the arch is
more than 10 mm Hg during routine catheter insertion
before the stage II procedure. Freedom from arch reinter-
vention was 79%  4% at 1 year and 76%  4% at 10
years. Figure 3, B illustrates that there was no difference
among groups A, B, and C on univariable analysis (P.71).
In addition, there was no difference whether the aortic back
wall was left in continuity (16%) or the coarctation was
resected completely (14%) (P .78).
Of 367 patients who underwent the NP, 226 (61.5%)
underwent stage II, and 98 (26.7%) had completion of
Fontan circulation (stage III). One hundred patients (27%)
required subsequent CPA patch augmentation at stage II.
Freedom from CPA patch augmentation was 61%  3% at
1 year, and was lower in group C (3%  3%) than group A
(80%  4%) or B (72%  5%, P .05; Figure 3, C). Group
C was more likely to have CPA patch augmentation than
group A or B on multivariable analysis (LR 7.41; 95% CI,
4.73-11.63).
After stage II, 41 patients (18%) required catheter-based
reintervention on CPAs, and almost all were directed to the
left pulmonary artery (99%). Actuarial freedom from
catheter-based reintervention was 98%  1% and 72% 
4% at 1 and 5 years, respectively. Multivariable analysis
showed that catheter-based reintervention of the CPAs has
become more common with time. Complete duct tissue and
coarctation resection independently increased the risk of
reintervention of the CPAs (LR 3.9; 95% CI, 1.6-9.6) after
stage II. Arch reconstruction or CPA defect closure tech-
niques did not affect the risk of reoperation or catheter-
based reintervention on CPAs.
Discussion
The management of HLHS continues to present one of the
greatest challenges in congenital heart surgery. The optimal
surgical management for patients with HLHS remains con-
troversial. Although alternative strategies, such as neonatal
orthotopic heart transplantation, have been advocated for
these patients,26 staged surgical palliation has gained in-
creasing acceptance as the primary treatment option for
these patients.7 Nevertheless, the NP for HLHS is associ-
ated with a high operative mortality, which is substantially
higher than that associated with other congenital cardiac
defects requiring neonatal repair. In the consensus-based
method of risk adjustment for in-hospital mortality among
children younger than 18 years after surgery for congenital
heart disease (Risk Adjustment for Congenital Heart Sur-
gery-1),27 the NP is included in the highest category (cate-
422 The Journal of Thoracic and Cardiovascular Surgery ● Febrgory 6). Many variations of the NP have been described,
and the optimum surgical strategy has not been clearly
defined. In particular, the type of arch reconstruction tech-
nique and source of pulmonary blood flow have been the
target areas for considerable debate.
Pulmonary Blood Flow
There have been numerous variations of the shunt supplying
pulmonary blood flow. Initially, there was a tendency to use
a central shunt in the belief that it would allow a more
uniform growth of CPAs.21 The central shunt, however, did
not eliminate the problem of distortion of CPAs at the site
of insertion, and it could be more difficult to take down.28
With the introduction of a smaller 3.5-mm shunt, the use of
right-side MBTS became the choice for most surgeons, and
it was routinely used at our institution until February 2002.
In 1981, Dr Norwood described a valved or nonvalved
conduit from the right ventricle to the distal main pulmo-
nary artery (RV-PA) to supply the pulmonary blood flow.6
The RV-PA conduit only gained popularity as an alternative
to the right MBTS after the reports of Kishimoto and
colleagues,29and subsequently Sano and colleagues.22 The
principal advantage of the RV-PA conduit is that it abol-
ishes the diastolic “runoff” from the systemic to the pulmo-
nary circulation, which characterizes the MBTS. This, in
turn, increases diastolic pressure and coronary perfusion
pressure.22 Abolishing the diastolic “runoff” may also en-
sure a more stable balance between the systemic and pul-
monary circulations, in which systemic and coronary blood
flow are less influenced by fluctuations in pulmonary vas-
cular resistance.23 A number of authors have highlighted the
improved early postoperative hemodynamics associated
with the RV-PA conduit compared with the right
MBTS.22,23
Hughes and colleagues25 also identified that the RV-PA
conduit was associated with improved early postoperative
right ventricular function. In addition, Pizarro and col-
leagues13 suggested that the RV-PA conduit might have a
beneficial impact on outcome after the NP. In the present
study, the modified NP with an RV-PA conduit was asso-
ciated with a substantial improvement in early mortality and
actuarial survival (Figure 3, A). The use of the RV-PA
conduit has become routine at our institution since March
2002.
Although we observed an improvement in the survival
after the introduction of RV-PA conduit, we were concerned
about the frequency and severity of the CPA stenoses at the
site of insertion of the conduit in this group of patients. The
majority of these patients required subsequent CPA patch
augmentation in contrast with patients in groups A and B
(Figure 3, C).
We initially considered that this problem might be a
technical issue related to the difficulty in sizing the length of
uary 2006
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obviate the problem, we explored the idea of shifting the
distal end of RV-PA conduit on the right side of the neo-
aorta, because the surgical approach to this area is easier and
patching of CPAs could be accomplished more easily than
on the left side of the aorta.
The RV-PA conduit, on the right side of the ascending
aorta, has a longer course, curving over the neoaorta, and
comes to lie just behind the sternum, which can pose some
problems for the resternotomy. Therefore, a Gore-Tex peri-
cardial membrane has been used routinely to close the
pericardium. Despite this change in the technique, used
routinely since February 2003, the same proportion of pa-
tients required subsequent patch augmentation of CPAs. At
6 months after the NP, the freedom from PA reconstruction
was 18%  12% and 22%  7% in the left- and right-sided
RV-PA groups, respectively (P .98).
A recent study performed at our institution30 showed that
despite an almost constant narrowing at the site of its
insertion on the CPAs, the RV-PA conduit seems to provide
a better growth of distal pulmonary arteries compared with
MBTS. We believe the narrowing that occurs with the
RV-PA conduit at the site of conduit insertion is a problem
inherent to this technique. However, a right-sided RV-PA
conduit offers the additional benefit of operating on the right
side of neoaorta, where the Glenn shunt has to be made.
Aortic Arch Reconstruction
Aortic arch reconstruction techniques have changed from
the original description made by Dr Norwood, which in-
volved the creation of neoaorta using the original proximal
pulmonary artery anastomosed to the ascending and proxi-
mal aortic arch.6 In 1986 Jonas and colleagues21 adopted a
different technique, based on the recognition that more than
80% of patients had coarctation that could not be dealt with
appropriately using the original Norwood technique. This
involved patching the proximal descending aorta well be-
yond the junction with the ductus arteriosus, the arch, and
the ascending aorta with allograft arterial wall (pulmonary
homograft). The pliability of the allograft patch allowed
minimal distortion at the most proximal point of ascending
aorta, and interrupted sutures were normally used in this
area. This technique has become widely adopted as the
standard method of arch reconstruction for HLHS.
In 1995, Bu’Lock and associates18 and Fraser and Mee20
reported a technique based on reconstruction of the neoaorta
without patch supplementation because of possible disad-
vantages of the homograft, such as lack of growth, degen-
eration, and calcification. All duct tissue was excised from
the anastomotic site, thus minimizing the risk for recoarc-
tation, and the neoaorta was refashioned by directly anas-
tomosing the proximal pulmonary artery, ascending aorta,
The Journal of Thoraciand aortic arch with the descending aorta, in a complex
Damus-Kaye-Stansel anastomosis.
In 1999, Ishino and colleagues19 described our experi-
ence with this technique in 120 neonates with HLHS. In
85% of cases, we were able to reconstruct the arch using a
direct aortic anastomosis. However, in 15%, the arch recon-
struction was supplemented with a pulmonary homograft
patch. This was primarily in patients in whom undue tension
on the arch or its branch arteries was unavoidable, or direct
aortic anastomosis caused the arch to become distorted. In
particular, the authors determined that a long, diminutive
ascending aorta (2.0 mm in diameter), ductal tissue in the
aortic arch with coarctation between the left carotid artery
and the left subclavian artery, a long ductus arteriosus with
a short descending thoracic aorta, and an aberrant right
subclavian artery were contradictions to this technique.
In addition, this direct anastomosis technique seems to be
technically demanding and surgeon-specific, requiring sev-
eral technical adjustments for each individual patient.
Therefore in April 1999 we adopted a second technique for
arch reconstruction with a homograft patch. This technique
has become the routine method at our institution, with minor
variations as described earlier.
According to the technique used, the management of
coarctation and the duct tissue has changed in accordance
with the techniques used to reconstruct the aortic arch. All
patients who had a complex Damus-Kaye-Stansel anasto-
mosis had complete excision of the coarctation and ductal
tissue. In contrast, aortic arch reconstruction with a ho-
mograft patch has allowed more individualized manage-
ment, leaving the aortic back wall in continuity in those
patients in whom the aortic coarctation was judged mild or
not present at all.
Statistical analysis did not show any difference in rein-
tervention rate on the neoaortic arch between the 2 tech-
niques (Figure 3, B). Nevertheless, patch augmentation
seems to provide a more standardized and easier surgical
procedure that could be applied to all patients irrespective of
arch morphology and other anatomic abnormalities. Fur-
thermore, this technique allows the surgeon to leave the
aortic back wall in continuity in selected cases. This is
important to maintain optimal alignment of the neoaortic
arch.
Irrespective of the technique used for the neoaorta re-
construction, patients who had complete duct tissue and
coarctation excision show a higher rate of catheter-based
reintervention after stage II on CPAs and particularly on the
left pulmonary artery, probably related to the long-standing
compression caused by the anastomoses around the coarc-
tation area.
Routine use of homograft patch supplementation, with or
without complete coarctation resection, does not show any
difference in causing distortion or compression of the CPAs
c and Cardiovascular Surgery ● Volume 131, Number 2 423
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tion, as demonstrated by a comparable rate of CPA patch
augmentation between groups A and B (Figure 3, C).
Considerable care is required to tailor the homograft
patch around the arch to avoid redundancy of tissue around
very narrow areas like the corner between the aortic arch,
descending aorta, and left pulmonary artery, or in the more
proximal part of the ascending aorta. This redundant allo-
graft material could degenerate over the time and lead to
compression of surrounding structures, particularly CPAs.
In contrary, undersizing the patch could lead to residual
gradient across the aortic arch. We believe that the use of
patch augmentation for the arch guarantees a more repro-
ducible and easier surgical technique. This reproducibility is
also important in the learning curve of surgeons who start to
deal with HLHS and related anomalies. The pliability of the
allograft material allows the surgeon to accommodate the
different anatomic variations and sizes of the vessels in-
volved in the anastomosis. We did not experience degener-
ation or other long-term problems with the homograft patch,
as initially suspected. Furthermore, a more extensive recon-
struction of the ascending aorta is achievable with the patch
technique, which may improve coronary perfusion.
Study Limitations
This study was designed to determine the influence of 3
different surgical strategies on outcome after the NP. Other
variables, including risk factors known to influence the
outcome after the NP, were not included in the analysis. The
influence of all these variables has been the subject of
another recent study from our institution.17
Conclusions
We showed an improvement in survival after the use of an
RV-PA conduit, but a greater proportion required subse-
quent pulmonary artery patch augmentation. The type of
arch reconstruction did not affect the incidence of arch
reintervention, but we believe that patch augmentation of
the arch with or without coarctation resection allows the
surgeons the ability to deal with all the variety of anatomic
problems encountered in HLHS. It is easier and more re-
producible; the allograft material offers excellent quality of
pliability and hemostasis, and does not seem to have long-
term problems such as shrinking, calcification, or other
degenerative changes.
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Discussion
Dr Thomas L. Spray (Philadelphia, Pa). I think this excellent
presentation has demonstrated quite a large experience with HLHS
with various modifications of the standard NP. The most recent
experience with the RV-PA shunt modification suggests an im-
proved survival with this newer technique. Our own experience
presented from the Children’s Hospital of Philadelphia in a con-
temporaneous group comparing these 2 strategies, however, did
not show any difference in early mortality or interstage mortality.
So I think one of the real limitations of this study is the fact that
this is a sequential comparison rather than a contemporaneous
comparison, and one would hope, at least, that all our results
improve over time.
Because this is not a contemporaneous comparison of different
techniques, I wonder if you would comment if there were any
changes in the operative strategies or the postoperative manage-
ment in these patients that might be contemporaneous with the
switch to the RV-PA shunt. I noticed, for example, that your use
of retrograde cerebral perfusion was almost contemporaneous with
that transition. Do you think this might have some impact on your
overall outcome?
Dr Griselli. Thank you, Dr Spray, for your remarks and ques-
tion. In terms of changes of technique, there really is no major
difference in what I explained in terms of surgical techniques and
shunt management. The population has not changed in the last 10
years in terms of numbers or pathologies. In view of the antenatal
diagnosis, we see more patients undergoing surgery who are more
stable and in better shape than they were in the past. So it has
probably been modified because of the population.
In terms of postoperative care, as in any branch of medicine,
there has been some improvement. But I believe that as we manage
the patient in the Children’s Hospital together with intensivists, the
RV-PA conduit presents the patient in a completely different
condition than previously. The patients are much more stable, the
management of inotropic support is much easier, and the fluid
management is much easier. So I think, yes, there have been some
The Journal of Thoraciimprovements in postoperative management, but I believe we also
offer to intensivists a big difference in terms of patients, in terms
of stability.
So I think this is difficult, of course, to extrapolate to what is
more important or if it has been an influence. But I believe that we
also have given them a much more stable patient. As we are
involved in the treatment of these patients, and having the luxury
to look at both types of the NP, I believe that has been a funda-
mental step forward.
Dr Spray. Other studies have suggested that anatomic and
genetic factors have a major influence on overall outcome and
mortality for this operation. You mentioned you had a high per-
centage of standard HLHS in this overall population, but you really
didn’t compare the distribution of anatomies, birth weights, and
other risk factors over the various time frames of the study. If you
did look at that, do you think they would be evenly distributed, or
do you think there has been an increase, for example, or a decrease
recently in more complex anatomies, low birth weights, and other
issues, since you, as you mentioned, have patients with a prenatal
diagnosis more commonly?
Dr Griselli. No, there has not been a difference. We just
finished a study on a risk model for an NP and the banding of
children, and there was no difference in terms of pathologies, and
that could occur in this program; basically it could alter what we
found in this study. So I don’t think that was an important factor.
Other problems we found, but not the pathologies, have been
changed in the last 10 years.
Dr Spray. I was struck by the fact that despite your improved
early survival, the interstage mortality was virtually identical in all
of the different parts of your series, dating back even to the earliest
portion of the series, and that would make me wonder whether the
hemodynamic benefits that are ascribed to the RV-PA shunt do not
really impact significantly on coronary perfusion or potential sud-
den death out of hospital. Would you comment on that? Why do
you think the interstage mortality is so high?
Dr Griselli. The interstage mortality has not changed. This is
one of the issues we are trying to address. As you said, if this
RV-PA conduit makes the children much more stable soon after
surgery, then maybe they are more fragile than the others. And we
found there is no statistical difference in patients who had an
RV-PA conduit undergoing the second stage earlier than the other
groups.
And the other problem is that some of the patients coming to
Children’s may be not local. We may be lacking some infrastruc-
ture to do surveillance on these children soon after surgery. We
should improve in that sense. We had the stepladder improvement
every year, even with other techniques in terms of early mortality,
but it seems not to be going so well in the long term. It should
improve in terms of looking after these patients better, after the
first month I would say.
Dr Spray. I thought it was interesting that when you compare
the techniques of arch reconstruction, whether you resect the
coarctation or not, whether you patch the aorta or not, the inci-
dence of reintervention on the aorta seems to be fairly consistent
among the various groups. So it would suggest that resection of
coarctation is not really necessary if you patch the aortic arch, and
yet resection of coarctation was associated with left pulmonary
artery stenosis. It seems unusual that leaving coarctation tissue in
c and Cardiovascular Surgery ● Volume 131, Number 2 425
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dilation of the aortic arch, but you did not find that. I wonder if you
would comment on that?
Dr Griselli. At the beginning of the study we thought that we
would find more incidence of recoarctation or more risk of rebal-
looning the arch than with the other technique. But this has not
happened. I believe that was described in 1998 in a meeting by the
same institution. The resection of coarctation was supposed to be
fundamental in the treatment of hypoplasty and not use any ma-
terial because otherwise it will calcify and degenerate. We now
have experience showing no difference in the 2 groups even after
10 years of further experience. So I think that is what we are
seeing.
We surprise ourselves as well. I thought there would be more.
It doesn’t surprise me that maybe leaving the coarctation alone
doesn’t create less incidence of balloon stent on the pulmonary
artery, particularly on the left side. We have seen basically 98% of
the cases. So we were surprised with the results of this.
Dr Spray. Just 1 final question. If you see so much PA
narrowing with the RV-PA shunt, and you virtually always have to
patch the pulmonary arteries, which is certainly our experience
also, I wonder whether you think it would be advisable to routinely
patch the pulmonary artery bifurcation at the time of the first stage
of operation if you’re going to have to do that anyway? Do you426 The Journal of Thoracic and Cardiovascular Surgery ● Febrmade, and maybe we should change, again, the way we do these
operations to decrease the risk of stenosis?
Dr Griselli. Yes, certainly. We’ve now committed that if we
are going to perform an RV-PA conduit, we think that at the next
stage we definitely are going to patch. So we believe it is correct
and connected to the techniques. And that’s why, believing that we
have to do this patching, we shifted the conduit to the right side
where we have to do the Glenn shunt, so it’s easier to approach
anyway.
Patching at the first stage has been tried in terms of local patch
where the shunt is going to be, but still results in a narrowing on
the subsequent angiogram.
Dr Spray. I enjoyed this study very much and look forward to
the results of a randomized prospective trial that compares these 2
operations to try to get at the answer of whether we really are
fundamentally changing the pathophysiology of this condition.
Dr S. Sano (Okayama, Japan). Congratulations on your excel-
lent results in this huge series.
Our series on the CPA construction after an RV-PA shunt has
acquired very few patients. We used the pericardium in the first 11
patients as a patch, and then we found that a lot of patients became
stenotic. Then we changed to the Gore-Tex cuff (29 cases), and
since then we found only 1 or 2 patients who required CPAthink this is a fundamental issue with the way the connection is construction. So I think there are technical things.uary 2006
